AI-Enabled Drug Discovery and Clinical Trials Market

Industry Overview

The market for AI-Enabled Drug Discovery and Clinical Trials has been growing rapidly in recent years, driven by advancements in AI technologies, the need for more efficient drug development processes, and the increasing availability of large-scale biomedical data. AI is being applied to various aspects of drug discovery and clinical trials, including target identification, lead generation, optimization of drug candidates, prediction of drug safety and efficacy, patient selection for clinical trials, and data analysis. The Global AI-Enabled Drug Discovery and Clinical Trials Market is anticipated to grow at a substantial rate i.e. from USD 0.60 billion In 2023 to USD 4.2 billion by 2030, registering a CAGR of 24.6% during the forecast period 2025-2030. AI for drug discovery is defined as a technology that is used to improve the process of decision-making for drug discovery. The market is driven by the rising demand to decrease the cost of new drug discovery and production, increasing incidences of rare diseases, need for personalized drugs.

Moreover, the use of AI is increasing rapidly to make the discovery of efficient and cost-effective drugs, resulting in gaining traction from the stakeholders in the pharmaceutical industry.  Moreover, the increasing drug development expenditure and a growing number of synergistic activities will bolster the growth of the AI-enabled drug discovery and clinical trials market. Nevertheless, various regulatory bodies like U.S. Food and Drug Administration (FDA) have provided guidelines and taken initiatives to encourage the implementation of AI in the drug discovery and development process.

The pharmaceutical and biotechnology industries are increasingly using AI to faster the process of drug development and enhance precision during the COVID-19 pandemic. Moreover, there is rising clinical R&D expenditure on various drugs leading to the growth of the AI-enabled drug discovery and clinical trials market during the pandemic.

Market Segmentation

Insight by Component

Based on the component, the global AI-enabled drug discovery and clinical trials market is bifurcated into solutions and services. The solutions segment is subdivided into aggregation & synthesis of information, drug design & validation, optimizing drug candidates, and others. The solution segment is anticipated to hold the largest share in the AI-enabled drug discovery and clinical trials market during the forecast period owing to the increasing cost of drug discovery and advancement process leading to the development of AI solutions. This will increase the time efficiency and curtail the cost of the drug discovery and development process.

Insight by Application

Based on the application, the global AI-enabled drug discovery and clinical trials market is segmented into data integration & analysis, clinical trials, drug design, drug characterization, biomarker research, and others. Among all the segments, the data aggregation and analysis segment is anticipated to dominate the market by 2030 as most of the companies in the market are offering solutions & services for data analysis. Also, the biomarker segment will witness the fastest growth during the forecast period 2025-2030.

Insight by Therapeutic Application

Based on the therapeutic applications, the global AI-enabled drug discovery and clinical trials market is divided into oncology, nervous system diseases, cardiovascular diseases, respiratory disorders, metabolic diseases, immunologic diseases, infectious diseases, and others. Among all the segments, the oncology segment dominates the market in 2022 owing to the crucial role played by AI in the early detection of cancer. AI-enabled drug discovery will find out the genetic mutations which will help oncologists to provide effective personalized medicine for cancer patients.

Insight by End-User

Based on the end-user, the global AI-enabled drug discovery and clinical trial market is divided into the biopharmaceutical industry, contract research organizations (CROs), and academic institutes and research & centers. The biopharmaceutical industry dominates the market due to the adoption of artificial intelligence (AI) which will offer drug manufacturers to increase the productivity of the drug development process and reduce the processing time.

Global AI-Enabled Drug Discovery and Clinical Trials Market Report Coverage

Industry Dynamics

Industry Trends

The increasing adoption of AI which includes machine learning, cloud computing, etc., increasing cross-industry collaboration, focus on the quality of care, and streamlining workflow facilities are the trends that will anticipate the growth of the AI-enabled drug discovery and clinical trials market.

Target Identification and Validation: AI algorithms can analyze large datasets of genetic, genomic, and proteomic data to identify potential drug targets and validate their relevance to specific diseases.

Drug Design and Optimization: AI techniques such as machine learning and deep learning can be used to generate and optimize drug candidates, predicting their properties, efficacy, and safety profiles.

Virtual Screening: AI algorithms can analyze large libraries of compounds and predict their potential for binding to specific drug targets, enabling more efficient screening of potential drug candidates.

Clinical Trial Optimization: AI can be used to design and optimize clinical trials, including patient selection criteria, trial protocols, and monitoring of patient responses during the trial.

Real-World Data Analysis: AI algorithms can analyze real-world patient data, electronic health records, and other sources of healthcare data to identify patterns, detect adverse events, and improve patient outcomes.

Growth Drivers

The rising awareness about the advantages of AI, 4K Imaging, and IoT among healthcare professionals, rising drug development expenditure, increasing need to reduce the drug discovery cost and time, rising number of agreements between pharmaceutical and IT companies, facilitation of polypharmacology, increasing use of cloud-based services, rising number of synergistic activities, are the drivers that propel the growth of the market.  Moreover, the use of AI will provide precision which in turn will reduce the complications and time-consuming process of the drug development, resulting in the fast development of drugs and reduce risk failure. These all factors will bolster the growth of the AI-enabled drug discovery and clinical trials market.

Challenges

Lack of regulations and ethical issues, high cost of AI implementation, and limited awareness may hinder the growth of the AI-enabled drug discovery and clinical trials market as certain countries like America and Europe are regulated but there are no proper guidelines in countries such as Asia-Pacific and the Middle East & African region. Moreover, lack of skilled staff and insufficient data sets for the discovery and development of medicines will impact the market growth.

Opportunities

The expansion of businesses in emerging economies like India and Brazil, and countries having a high geriatric populace like Japan and China will create lucrative opportunities for growth in the AI-enabled drug discovery and clinical trials market. The AI-enabled drug discovery and clinical trials market includes various stakeholders, including pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutions, and AI technology providers. Several startups and established companies are actively involved in developing and commercializing AI solutions for drug discovery and clinical trials.The market is expected to continue growing in the coming years, driven by the increasing adoption of AI technologies, advancements in computational power, and the need for more efficient and cost-effective drug development processes. However, there are also challenges to overcome, such as regulatory considerations, data privacy concerns, and the need for robust validation and interpretation of AI-generated results.

Geographic Overview

North America is anticipated to hold the largest market share in the AI-enabled drug discovery and clinical trials market owing to the presence of market players in the region., rising need to develop novel treatments for rare diseases, increasing R&D expenditure, an increasing number of clinical trials, and significant investment in the healthcare sector by USA government.

Competitive Insight

The industry players are expanding their customer base in various countries to compete on product price and efficiency. These industry players are leveraging strategic collaboration initiatives and partnerships  to expand their geographical reach and improve their profitability

The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

Some of the key players operating in the global AI-enabled drug discovery and clinical trials market: Accutar Biotechnology Inc., AiCure, Ardigen, Atomwise inc., BERG LLC, Biovista, Cloud Pharmaceuticals, Inc., Cyclica Inc., Symphony Innovation, LLC, and Benevolent AI.

The AI-Enabled Drug Discovery and Clinical Trials Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Component 
  • Solutions
  • Services
• By Application
  • Data Integration & Analysis
  • Clinical Trials
  • Drug Design
  • Drug Characterization
  • Biomarker Research
  • Others
• By Therapeutic Application 
  • Oncology
  • Nervous System Diseases
  • Cardiovascular Diseases
  • Respiratory Disorders
  • Metabolic Diseases
  • Immunologic Diseases
  • Infectious Diseases
  • Others
• By End-User
  • Biopharmaceutical Industry
  • Contract Research Organizations (CROs)
  • Academic Institutes & Research Centers

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Component
                1.2.2.    By Application 
                1.2.3.    By Therapeutic Application
                1.2.4.    By End-User
                1.2.5.    By Region
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                1.5.1.    Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2.    Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Component
                5.1.1.    Solutions
                        5.1.1.1. Market Definition
                        5.1.1.2. Market Estimation and Forecast to 2030  
                5.1.2.    Services
                        5.1.2.1. Market Definition
                        5.1.2.2. Market Estimation and Forecast to 2030
        5.2.    By Application
                5.2.1.    Data Integration & Analysis
                        5.2.1.1. Market Definition
                        5.2.1.2. Market Estimation and Forecast to 2030
                5.2.2.    Clinical Trials
                        5.2.2.1. Market Definition
                        5.2.2.2. Market Estimation and Forecast to 2030
                5.2.3.    Drug Design
                        5.2.3.1. Market Definition
                        5.2.3.2. Market Estimation and Forecast to 2030
                5.2.4.    Drug Characterization
                        5.2.4.1. Market Definition
                        5.2.4.2. Market Estimation and Forecast to 2030
                5.2.5.    Biomarker Research
                        5.2.5.1. Market Definition
                        5.2.5.2. Market Estimation and Forecast to 2030
                5.2.6.    Others
                        5.2.6.1. Market Definition
                        5.2.6.2. Market Estimation and Forecast to 2030
        5.3.    By Therapeutic Application   
                5.3.1.    Oncology
                        5.3.1.1. Market Definition
                        5.3.1.2. Market Estimation and Forecast to 2030
                5.3.2.    Nervous System Diseases
                        5.3.2.1. Market Definition
                        5.3.2.2. Market Estimation and Forecast to 2030
                5.3.3.    Cardiovascular Diseases
                        5.3.3.1. Market Definition
                        5.3.3.2. Market Estimation and Forecast to 2030
                5.3.4.    Respiratory Disorders
                        5.3.4.1. Market Definition
                        5.3.4.2. Market Estimation and Forecast to 2030
                5.3.5.    Metabolic Diseases
                        5.3.5.1. Market Definition
                        5.3.5.2. Market Estimation and Forecast to 2030
                5.3.6.    Immunologic Diseases
                        5.3.6.1. Market Definition
                        5.3.6.2. Market Estimation and Forecast to 2030
                5.3.7.    Infectious Diseases
                        5.3.7.1. Market Definition
                        5.3.7.2. Market Estimation and Forecast to 2030
                5.3.8.    Others
                        5.3.8.1. Market Definition
                        5.3.8.2. Market Estimation and Forecast to 2030
        5.4.    By End-User
                5.4.1.    Biopharmaceutical Industry
                        5.4.1.1. Market Definition
                        5.4.1.2. Market Estimation and Forecast to 2030
                5.4.2.    Contract Research Organizations (CROs)
                        5.4.2.1. Market Definition
                        5.4.2.2. Market Estimation and Forecast to 2030
                5.4.3.    Academic Institutes & Research Centers
                        5.4.3.1. Market Definition
                        5.4.3.2. Market Estimation and Forecast to 2030

6.    North America Market Estimate and Forecast

        6.1.    By Component
        6.2.    By Application 
        6.3.    By Therapeutic Application
        6.4.    By End-User
        6.5.    By Country
                6.5.1.    U.S. Market Estimate and Forecast
                6.5.2.    Canada Market Estimate and Forecast
                6.5.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Component
        7.2.    By Application 
        7.3.    By Therapeutic Application
        7.4.    By End-User
        7.5.    By Country
                7.5.1.    Germany Market Estimate and Forecast
                7.5.2.    France Market Estimate and Forecast
                7.5.3.    U.K. Market Estimate and Forecast
                7.5.4.    Italy Market Estimate and Forecast
                7.5.5.    Spain Market Estimate and Forecast
                7.5.6.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Component
        8.2.    By Application
        8.3.    By Thaerapeutic Application
        8.4.    By End-User        
        8.5.    By Country
                8.5.1.    China Market Estimate and Forecast
                8.5.2.    Japan Market Estimate and Forecast
                8.5.3.    India Market Estimate and Forecast
                8.5.4.    South Korea Market Estimate and Forecast
                8.5.5.    Singapore Market Estimate and Forecast
                8.5.6.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Component
        9.2.    By Application 
        9.3.    By Therapeutic Application
        9.4.    By End-User
        9.5.    By Country
                9.5.1.    Brazil Market Estimate and Forecast
                9.5.2.    Saudi Arabia Market Estimate and Forecast
                9.5.3.    South Africa Market Estimate and Forecast
                9.5.4.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    Accutar Biotechnology Inc.
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    AiCure
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    Ardigen
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Atomwise Inc.
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    BERG LLC
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    Biovista
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    Cloud Pharmaceuticals, Inc.
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Cyclica Inc.
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    Symphony Innovation, LLC
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10.    Benevolent AI
                10.10.1. Snapshot
                10.10.2. Overview
                10.10.3. Offerings
                10.10.4. Financial Insight
                10.10.5. Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2023 (USD Billion)
Table 5 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2025 - 2030 (USD Billion)
Table 6 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2023 (USD Billion)
Table 7 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2025 - 2030 (USD Billion)
Table 8 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2023 (USD Billion)
Table 9 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2025 - 2030 (USD Billion)
Table 10 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 11 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 12 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2023 (USD Billion)
Table 13 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2025 - 2030 (USD Billion)
Table 14 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2023 (USD Billion)
Table 15 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2025 - 2030 (USD Billion)
Table 16 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2023 (USD Billion)
Table 17 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2025 - 2030 (USD Billion)
Table 18 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2023 (USD Billion)
Table 19 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2025 - 2030 (USD Billion)
Table 20 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 21 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 22 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Distribution Channel, 2018 - 2023 (USD Billion)
Table 23 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2023 (USD Billion)
Table 24 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2025 - 2030 (USD Billion)
Table 25 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2023 (USD Billion)
Table 26 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2025 - 2030 (USD Billion)
Table 27 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2023 (USD Billion)
Table 28 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2025 - 2030 (USD Billion)
Table 29 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2023 (USD Billion)
Table 30 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2025 - 2030 (USD Billion)
Table 31 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 32 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 33 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2023 (USD Billion)
Table 34 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2025 - 2030 (USD Billion)
Table 35 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2023 (USD Billion)
Table 36 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2025 - 2030 (USD Billion)
Table 37 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2023 (USD Billion)
Table 38 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2025 - 2030 (USD Billion)
Table 29 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2023 (USD Billion)
Table 40 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2025 - 2030 (USD Billion)
Table 41 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 42 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 43 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2023 (USD Billion)
Table 44 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2025 - 2030 (USD Billion)
Table 45 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2023 (USD Billion)
Table 46 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2025 - 2030 (USD Billion)
Table 47 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2023 (USD Billion)
Table 48 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2025 - 2030 (USD Billion)
Table 49 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2023 (USD Billion)
Table 50 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2025 - 2030 (USD Billion)
Table 51 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2023 (USD Billion)
Table 52 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2025 - 2030 (USD Billion)
Table 53 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2023 (USD Billion)
Table 54 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2025 - 2030 (USD Billion)
Table 55 Snapshot – Accutar Biotechnology Inc.
Table 56 Snapshot – AiCure
Table 57 Snapshot – Ardigen 
Table 58 Snapshot – Atomwise Inc.
Table 59 Snapshot – BERG LLC
Table 60 Snapshot – Biovista
Table 61 Snapshot – Cloud Pharmaceuticals, Inc.
Table 62 Snapshot – Cyclica Inc.
Table 63 Snapshot – Symphony Innovation, LLC
Table 64 Snapshot – Benevolent AI

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global AI-Enabled Drug Discovery and Clinical Trials Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global AI-Enabled Drug Discovery and Clinical Trials Market Highlight
Figure 12 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2030 (USD Billion)
Figure 13 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 14 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2030 (USD Billion)
Figure 15 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2030 (USD Billion)
Figure 16 Global AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 17 North America AI-Enabled Drug Discovery and Clinical Trials Market Highlight
Figure 18 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2030 (USD Billion)
Figure 19 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 20 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2030 (USD Billion)
Figure 21 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2030 (USD Billion)
Figure 22 North America AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 23 Europe AI-Enabled Drug Discovery and Clinical Trials Market Highlight
Figure 24 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2030 (USD Billion)
Figure 25 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 26 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2030 (USD Billion)
Figure 27 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2030 (USD Billion)
Figure 28 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 29 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Highlight
Figure 30 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2030 (USD Billion)
Figure 31 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 32 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2030 (USD Billion)
Figure 33 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2030 (USD Billion)
Figure 34 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 35 RoW AI-Enabled Drug Discovery and Clinical Trials Market Highlight
Figure 36 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Component, 2018 - 2030 (USD Billion)
Figure 37 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 38 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By Therapeutic Application, 2018 - 2030 (USD Billion)
Figure 39 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, By End-User, 2018 - 2030 (USD Billion)
Figure 40 RoW AI-Enabled Drug Discovery and Clinical Trials Market Size, by Region, 2018 - 2030 (USD Billion)